US equities had a mixed and volatile week. Weekly market recap
US stocks finished a volatile week with mixed results as Nvidia’s blockbuster earnings boosted technology shares, while Federal Reserve...
Welcome to the Tech section of Finblog.com, where we explore the cutting-edge advancements and trends in technology that are reshaping the financial landscape. This category is dedicated to providing you with insightful analysis and updates on the latest technological innovations and their impact on finance and business.
Meta’s $18 Billion Settlement Could Be a Win for Investors
Meta’s $18 billion child-safety settlement is one of the largest agreements of its kind, but for investors, the deal...
Nvidia Is Increasingly Financing Its Own AI Boom
Nvidia is no longer just selling the chips powering the artificial intelligence boom. It is increasingly using its own...
AI’s Trillion-Dollar Question: Can Boom Generate Enough Value to Pay for Itself?
AI investment is moving from billions into trillions of dollars, raising one of the biggest questions facing technology investors:...
Nvidia Agrees to Buy Hugging Face for $12.9 Billion in Major AI Deal
Nvidia has agreed to acquire Hugging Face for $12.9 billion, giving the world’s dominant AI chipmaker control of one...
Meta Agrees to Nearly $18 Billion Settlement Over Harm to Children
Meta has agreed to pay about $18 billion to resolve a major legal battle over allegations that Facebook and...
Workers in China worry over being replaced as they adapt to the growing impact of AI on jobs
China is rapidly deploying AI across its economy, bringing productivity gains but also growing fears that millions of workers...
Alibaba’s AI Bet Starts Paying Off as Cloud Growth Hits Five-Year High
Alibaba’s huge AI spending is starting to produce clearer results. Revenue rose 9% year over year to $39.6 billion,...
Behind the Curtain: The new existential threat to AI
The biggest threat to America’s AI boom may no longer be competition from China or a shortage of advanced...
Promising Results for mRNA Cancer Vaccine from Moderna and Merck
Moderna and Merck have reported encouraging late-stage results for their personalized mRNA cancer vaccine, marking an important step toward...